This past week, from Monday, 23 November to Friday, 27 November, Cancer Institute NSW announced the winners of the NSW Premier’s Awards for Outstanding Cancer Research 2020.
Sydney Vital would like to congratulate each awardee and especially highlight A/Prof Angela Chou, Sydney Vital seed funding awardee, who was awarded the Outstanding Cancer Research Fellow – Early Career Fellow award. This award is presented each year to an early career researcher who has demonstrated exceptional research progress over the previous calendar year and grants recipients $10,000 towards their research endeavours.
A/Prof Chou was recognised at the NSW Premier’s Awards previously with the Rising Star award in 2015 for her pioneering research in the field of gastrointestinal and pancreatic cancers, which was part of her PhD project at the Garvan Institute. Five years later, she has returned to the awards and is now a cancer researcher at the Kolling Institute at the Royal North Shore Hospital (RNSH) as well as a practicing diagnostic pathologist at RNSH and Clinical Associate Professor at the University of Sydney.
A/Prof Chou’s research focuses on pancreatic cancer, a cancer with a poor five-year relative survival rate (10.7%) that is often detected late, with an eye towards improving treatments and, ultimately, patient outcomes and survival.
“Receiving recognition is flattering and humbling – it is a great honour. The Cancer Institute support has helped me tremendously, giving me the autonomy to develop my skills, confidence and ability as an independent researcher,” A/Prof Chou told CINSW. Read more about her research and her award here.
Winners of the 2020 NSW Premier’s Awards for Outstanding Cancer Research:
A/Prof Angela Chou – Outstanding Cancer Research Fellow – Early Career Fellow Award
Professor Richard Scolyer – Outstanding Cancer Researcher of the Year Award
Dr Orazio Vittorio – Outstanding Cancer Research Fellow – Career Development Fellow
Dr James Wilmott – Wildfire Highly Cited Publication Award
Hunter New England Cancer Clinical Research Network – Outstanding Cancer Clinical Trials Unit